申请人:Takeda Pharmaceutical Company Limited
公开号:US08314088B2
公开(公告)日:2012-11-20
Provided is a compound having a serotonin 5-HT2C receptor activating action.
A compound represented by the formula (I0):
wherein each symbol is as defined in the specification, or a salt thereof.
提供了一种具有5-羟色胺5-HT2C受体激活作用的化合物。所述化合物由公式(I0)表示:其中每个符号如规范中所定义,或其盐。